Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1140029.RArld-tzAkt5fnnp69-HIVGE9ER5vXDjem1_nYUIQUW9Y130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1140029.RArld-tzAkt5fnnp69-HIVGE9ER5vXDjem1_nYUIQUW9Y130_assertion type Assertion NP1140029.RArld-tzAkt5fnnp69-HIVGE9ER5vXDjem1_nYUIQUW9Y130_head.
- NP1140029.RArld-tzAkt5fnnp69-HIVGE9ER5vXDjem1_nYUIQUW9Y130_assertion description "[Long-term follow-up of R-CHOP with bevacizumab as initial therapy for mantle cell lymphoma: clinical and correlative results.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1140029.RArld-tzAkt5fnnp69-HIVGE9ER5vXDjem1_nYUIQUW9Y130_provenance.
- NP1140029.RArld-tzAkt5fnnp69-HIVGE9ER5vXDjem1_nYUIQUW9Y130_assertion evidence source_evidence_literature NP1140029.RArld-tzAkt5fnnp69-HIVGE9ER5vXDjem1_nYUIQUW9Y130_provenance.
- NP1140029.RArld-tzAkt5fnnp69-HIVGE9ER5vXDjem1_nYUIQUW9Y130_assertion SIO_000772 24373788 NP1140029.RArld-tzAkt5fnnp69-HIVGE9ER5vXDjem1_nYUIQUW9Y130_provenance.
- NP1140029.RArld-tzAkt5fnnp69-HIVGE9ER5vXDjem1_nYUIQUW9Y130_assertion wasDerivedFrom befree-2016 NP1140029.RArld-tzAkt5fnnp69-HIVGE9ER5vXDjem1_nYUIQUW9Y130_provenance.
- NP1140029.RArld-tzAkt5fnnp69-HIVGE9ER5vXDjem1_nYUIQUW9Y130_assertion wasGeneratedBy ECO_0000203 NP1140029.RArld-tzAkt5fnnp69-HIVGE9ER5vXDjem1_nYUIQUW9Y130_provenance.